Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors

被引:0
|
作者
Martinez-Arranz, Ibon [1 ]
Bruzzone, Chiara [2 ]
Noureddin, Mazen [3 ]
Gil-Redondo, Ruben [2 ]
Arretxe, Enara [1 ]
Iruarrizaga-Lejarreta, Marta [1 ]
Bizkarguenaga, Maider [2 ]
Minchole, Itziar [1 ]
Fernandez Ramos, David [2 ,4 ]
Lopitz Otsoa, Fernando [2 ]
Mayo, Rebeca
Embade, Nieves [2 ]
Newberry, Elizabeth [5 ,6 ]
Mittendorf, Bettina [7 ]
Izquierdo-Sanchez, Laura [8 ]
Perez Castano, Ylenia [9 ]
Smid, Vaclav [10 ,11 ]
Arnold, Jorge [12 ]
Krawczyk, Marcin [13 ,14 ]
Iruzubieta, Paula [15 ]
Marigorta, Urko M. [16 ]
Morrison, Martine C. [17 ]
Kleemann, Robert [17 ]
Duce, Antonio Martin [18 ]
Hayardeny, Liat [19 ]
Vitek, Libor [10 ,11 ]
Bruha, Radan [10 ,11 ]
Aller, Rocio [20 ,21 ]
Crespo, Javier [15 ]
Romero Gomez, Manuel [22 ]
Maria Banales, Jesus [4 ,8 ]
Arrese, Marco [12 ]
Cusi, Kenneth [23 ]
Bugianesi, Elisabetta [24 ]
Klein, Samuel [7 ]
Lu, Shelly C.
Anstee, Quentin [25 ]
Millet, Oscar [2 ]
Davidson, Nicholas O. [5 ,6 ]
Alonso, Cristina [1 ]
Mato, Jose M. [2 ,4 ]
机构
[1] OWL Metabol, Derio, Spain
[2] CIC bioGUNE Ctr Invest Cooperat Biociencias Preci, Derio, Spain
[3] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA
[4] ISCIII, CIBERehd, Madrid, Spain
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[6] Dept Dev Biol, St Louis, MO USA
[7] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO USA
[8] Donostia Univ Hosp, Biodonostia Res Inst, Dept Liver & Gastrointestinal Dis, San Sebastian, Spain
[9] Donostia Univ Hosp, Dept Digest Syst, Osakidetza Basque Hlth Serv, San Sebastian, Spain
[10] Charles Univ Prague, Fac Gen Hosp, Prague, Czech Republic
[11] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[12] Pontificia Univ Catolica Chile, Sch Med, Dept Gastroenterol, Santiago, Chile
[13] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Lab Metab Liver Dis, Warsaw, Poland
[14] Saarland Univ, Dept Med 2, Med Ctr, Homburg, Germany
[15] Univ Cantabria, Marques de Valdecilla Univ Hosp, Res Inst Marques de Valdecilla IDIVAL, Dept Digest Dis, Santander, Spain
[16] CIC bioGUNE, Integrat Genom Lab, Derio, Spain
[17] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands
[18] Alcala Univ, Univ Hosp Principe Asturias, Alcala De Henares, Spain
[19] Galmed Pharmaceut Ltd, Tel Aviv, Israel
[20] Univ Valladolid, Univ Hosp, Valladolid, Spain
[21] Dept Digest Dis, Valladolid, Spain
[22] Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, CSIC, Seville, Spain
[23] Univ Florida, Div Endocrinol Diabet & Metab, Gainesville, FL USA
[24] Univ Turin, Dept Gastroenterol, Turin, Italy
[25] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT014
引用
收藏
页码:S671 / S672
页数:2
相关论文
共 50 条
  • [1] Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
    Martinez-Arranz, Ibon
    Bruzzone, Chiara
    Noureddin, Mazen
    Gil-Redondo, Ruben
    Minchole, Itziar
    Bizkarguenaga, Maider
    Arretxe, Enara
    Iruarrizaga-Lejarreta, Marta
    Fernandez-Ramos, David
    Lopitz-Otsoa, Fernando
    Mayo, Rebeca
    Embade, Nieves
    Newberry, Elizabeth
    Mittendorf, Bettina
    Izquierdo-Sanchez, Laura
    Smid, Vaclav
    Arnold, Jorge
    Iruzubieta, Paula
    Perez Castano, Ylenia
    Krawczyk, Marcin
    Marigorta, Urko M.
    Morrison, Martine C.
    Kleemann, Robert
    Martin-Duce, Antonio
    Hayardeny, Liat
    Vitek, Libor
    Bruha, Radan
    Aller de la Fuente, Rocio
    Crespo, Javier
    Romero-Gomez, Manuel
    Banales, Jesus M.
    Arrese, Marco
    Cusi, Kenneth
    Bugianesi, Elisabetta
    Klein, Samuel
    Lu, Shelly C.
    Anstee, Quentin M.
    Millet, Oscar
    Davidson, Nicholas O.
    Alonso, Cristina
    Mato, Jose M.
    HEPATOLOGY, 2022, 76 (04) : 1121 - 1134
  • [2] NAFLD SUBTYPES WITH IMPAIRED VLDL SECRETION SEGREGATE WITH CARDIOVASCULAR AND CANCER RISK FACTORS
    Bruzzone, Chiara
    Noureddin, Mazen
    Martinez-Arranz, Ibon
    Iruarrizaga-Lejarreta, Marta
    Gil-Redondo, Ruben
    Newberry, Elizabeth P.
    Arretxe, Enara
    Bizkarguenaga, Maider
    Lanza, Borja
    Embade, Nieves
    Minchole, Itziar
    Mayo, Rebeca
    Fernandez Ramos, David
    Lopitz-Otsoa, Fernando
    Millet, Oscar
    Davidson, Nicholas O.
    Alonso, Cristina
    Lug, Shelly C.
    Mato, Jose M.
    HEPATOLOGY, 2020, 72 : 1054 - 1055
  • [3] Cardiovascular risk factors and fibrosisseverity in NAFLD: is there a link?
    Roccarina, D.
    Guerrero, M.
    Prat, L. I.
    Buzzetti, E.
    Goyale, A.
    Arico, F.
    Arico, F.
    Rosselli, M.
    Pinzani, M.
    Tsochatzis, E.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S830 - S830
  • [4] POLYCYSTIC OVARIAN SYNDROME IS AN INDEPENDENT RISK ASSOCIATION FOR NAFLD AFTER CONTROLLING FOR METABOLIC AND GENETIC RISK FACTORS
    Mezina, Anya I.
    Vujkovic, Marijana
    Schneider, Carolin Victoria
    Mukherjee, Samiran
    Park, Joseph
    Sagreiya, Hersh
    Witschey, Walter R.
    Chang, Kyong-Mi
    Kaplan, David E.
    Wangensteen, Kirk J.
    Rader, Daniel J.
    HEPATOLOGY, 2023, 78 : S1027 - S1028
  • [5] Genetic and epigenetic factors determining NAFLD risk
    Jonas, Wenke
    Schuermann, Annette
    MOLECULAR METABOLISM, 2020, 50
  • [6] Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia
    Smilde, TJ
    van Wissen, S
    Wollersheim, H
    Kastelein, JJP
    Stalenhoef, AFH
    NETHERLANDS JOURNAL OF MEDICINE, 2001, 59 (04): : 184 - 195
  • [7] Cardiovascular risk factors are independent of fibrosis severity in NAFLD
    Roccarina, D.
    Buzzetti, E.
    Misas, M. G.
    Rosselli, M.
    Majumdar, A.
    Pinzani, M.
    Tsochatzis, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S154 - S154
  • [8] Cardiovascular risk factors and fibrosis severity in NAFLD: is there a link?
    Roccarina, Davide
    Prat, Laura Iogna
    Guerrero, Marta
    Buzzetti, Elena
    Mantovani, Anna
    Goyale, Atul
    Arico', Francesco
    Saffioti, Francesca
    Pinzani, Massimo
    Tsochatzis, Emmanuel
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E308 - E308
  • [9] Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
    Dabravolski, Siarhei A.
    Bezsonov, Evgeny E.
    Baig, Mirza S.
    Popkova, Tatyana V.
    Nedosugova, Ludmila V.
    Starodubova, Antonina V.
    Orekhov, Alexander N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [10] NAFLD and cardiovascular risk
    Wong, Vincent Wai-Sun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 46 - 47